发明名称 |
Anti-FcRH5 antibodies and immunoconjugates and methods of use |
摘要 |
A method of determining the presence of FcRH5 in a biological sample suspected of containing FcRH5 is provided comprising exposing the biological sample to an isolated monoclonal anti-FcRH5 antibody. |
申请公布号 |
US9017951(B2) |
申请公布日期 |
2015.04.28 |
申请号 |
US201213673565 |
申请日期 |
2012.11.09 |
申请人 |
Genenech, Inc. |
发明人 |
Elkins Kristi;Polson Andrew;Ebens Allen;Adams Camelia;Zheng Bing;Junutula Jagath R.;Hongo Jo-Anne;Wu Yan |
分类号 |
G01N33/53;G01N33/574;A61K39/395;A61K45/06;C07K16/28;A61K31/69;A61K39/00 |
主分类号 |
G01N33/53 |
代理机构 |
Arnold & Porter LLP |
代理人 |
Lewis Michelle;Dreger Ginger;Arnold & Porter LLP |
主权项 |
1. A method of determining the presence of FcRH5 in a biological sample suspected of containing FcRH5, said method comprising exposing said sample to an isolated monoclonal anti-FcRH5 antibody comprising:
(a) a light chain variable domain comprising:
(i) HVR-L1 comprising the sequence KASQNVGSNVA (SEQ ID NO: 28);(ii) HVR-L2 comprising the sequence SASYRYS (SEQ ID NO: 29); and(iii) HVR-L3 comprising the sequence QQYKTWT (SEQ ID NO: 30); and (b) a heavy chain variable domain comprising:
(i) HVR-H1 comprising the sequence GYTFTNYGMN (SEQ ID NO: 37) or GYTFTNYGIN (amino acid residues 26-35 of SEQ ID NO:22);(ii) HVR-H2 comprising the sequence NTYTGEPTYTDDFKG (SEQ ID NO: 38); and(iii) HVR-H3 comprising the sequence ARRSIPYYYAMDY (SEQ ID NO: 39), anddetermining binding of said antibody to FcRH5 in said sample wherein binding of said antibody to FcRH5 in said sample is indicative of the presence of FcRH5 in said sample. |
地址 |
South San Francisco CA US |